STIMUFEND® (pegfilgrastim-fpgk)

STIMUFEND®(pegfilgrastim-fpgk)is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.


File format
PDF
Published
16 November, 2023
Updated
16 November, 2023
MD5 checksum
1004F290F0BC35EE14E5A52EE70F2D7D
Download PDF

Also Manuals